Streetbeat News

Products Services

NNOX

Nanox.AI, a subsidiary of Nanox, has received FDA 510(k) clearance for its HealthCCSng V2.0 product, which introduces 'Zero Calcium' categorization and a numerical coronary artery calcium score. This marks the second FDA clearance for the HealthCCSng product.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:05 pm

LUCY

Innovative Eyewear is partnering with Geenee to enhance augmented reality retail experiences for their ChatGPT Smart Eyewear, including the launch of the Lucyd Kiosk and improved virtual try-on technology.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:03 pm

ACON

Aclarion, Inc. has launched the CLUE Trial to assess how often Nociscan's AI-generated biomarker data influences changes in surgical treatment plans for chronic low back pain. This trial will involve multiple physicians and sites, contributing to Aclarion's clinical evidence.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:02 pm

BLK

ETHE

GBTC

GS

Grayscale appoints Peter Mintzberg, a Wall Street veteran, as its new CEO to navigate growth and regulatory challenges. This move comes after converting its Bitcoin trust into an ETF and facing competition from BlackRock and Fidelity.

Portfolio Pulse from Murtuza Merchant

August 21, 2024 | 12:02 pm

MNPR

Monopar Therapeutics has received clearance from the Australia Human Research Ethics Committee to proceed with a Phase 1 trial of its novel radiopharmaceutical for advanced cancers. This marks a significant step in the development of their cancer treatment pipeline.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:02 pm

SMFL

Smart for Life is negotiating the acquisition of four profitable health and wellness companies, which could expand its market presence and enhance its financial performance.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:00 pm

FAS

FAZ

GS

JPM

MA

PGR

V

The article discusses the potential for lower interest rates by the Federal Reserve amid economic challenges, highlighting the performance of financial institutions and leveraged ETFs. JPMorgan Chase, Goldman Sachs, Visa, and Mastercard have shown resilience, while Progressive Corp indicates a flight to safety. Direxion's leveraged ETFs, FAS and FAZ, offer speculative opportunities in this uncertain market environment.

Portfolio Pulse from Joshenomoto@benzinga.com

August 21, 2024 | 11:58 am

BPTH

Bio-Path Holdings shares rise following positive updates from their clinical trials. The company reported progress in its Phase 1/1b trial of BP1001-A for solid tumors and its Phase 2 study of prexigebersen in Acute Myeloid Leukemia.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 11:55 am

ARWR

Arrowhead Pharmaceuticals is set to present new Phase 3 clinical data from the Palisade study of Plozasiran at the European Society of Cardiology Congress 2024.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 11:41 am

BA

LLY

PANW

U.S. stock markets closed lower, breaking an eight-day winning streak, with energy stocks declining and consumer staples gaining. Eli Lilly's shares rose due to positive drug results, while Palo Alto Networks saw a significant jump on strong forecasts. Boeing fell after an FAA directive. Asian markets were mixed, and European markets advanced. Commodities showed varied movements, with gold near all-time highs.

Portfolio Pulse from Akanksha Bakshi

August 21, 2024 | 11:37 am